{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cream&page=10", "query": { "intervention": "Cream", "page": 10 }, "page_size": 10 }, "pagination": { "page": 10, "page_size": 10, "total_count": 998, "total_pages": 100, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cream&page=11&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cream&page=9&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T11:06:53.610Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01122342", "title": "Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Vaginitis", "Dyspareunia", "Breast Neoplasms" ], "interventions": [ { "name": "Testosterone propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Vermont", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 30, "start_date": "2006-12", "completion_date": "2011-01", "has_results": false, "last_update_posted_date": "2010-05-13", "last_synced_at": "2026-10-25T11:06:53.610Z", "location_count": 2, "location_summary": "Pawtucket, Rhode Island • Burlington, Vermont", "locations": [ { "city": "Pawtucket", "state": "Rhode Island" }, { "city": "Burlington", "state": "Vermont" } ], "official_url": "https://clinicaltrials.gov/study/NCT01122342" }, { "nct_id": "NCT02260986", "title": "Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Dupilumab", "type": "DRUG" }, { "name": "Placebo (for Dupilumab)", "type": "DRUG" }, { "name": "Topical Corticosteroid (TCS)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 740, "start_date": "2014-09", "completion_date": "2016-10", "has_results": true, "last_update_posted_date": "2017-10-17", "last_synced_at": "2026-10-25T11:06:53.610Z", "location_count": 50, "location_summary": "Phoenix, Arizona • Hot Springs, Arkansas • Little Rock, Arkansas + 47 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Encinitas", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02260986" }, { "nct_id": "NCT02227290", "title": "Pediatric Subjects With Tinea Corporis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tinea Corporis" ], "interventions": [ { "name": "Naftin Cream", "type": "DRUG" }, { "name": "Placebo Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merz North America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 230, "start_date": "2014-08", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-10-25T11:06:53.610Z", "location_count": 14, "location_summary": "Tucson, Arizona • Encino, California • Fremont, California + 10 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Encino", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02227290" }, { "nct_id": "NCT01502020", "title": "A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Actinic Keratoses" ], "interventions": [ { "name": "imiquimod cream, 3.75%", "type": "DRUG" }, { "name": "Vehicle Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Mid-Atlantic LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 410, "start_date": "2011-02", "completion_date": "2011-11", "has_results": false, "last_update_posted_date": "2011-12-30", "last_synced_at": "2026-10-25T11:06:53.610Z", "location_count": 19, "location_summary": "Birmingham, Alabama • Miami, Florida • Newnan, Georgia + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Miami", "state": "Florida" }, { "city": "Newnan", "state": "Georgia" }, { "city": "Boise", "state": "Idaho" }, { "city": "Arlington Heights", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01502020" }, { "nct_id": "NCT06488742", "title": "The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dermatitis, Atopic", "Pruritus" ], "interventions": [ { "name": "3% kanuka oil", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Nexgen Dermatologics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 60, "start_date": "2023-11-01", "completion_date": "2025-03-20", "has_results": false, "last_update_posted_date": "2024-07-05", "last_synced_at": "2026-10-25T11:06:53.610Z", "location_count": 1, "location_summary": "Boynton Beach, Florida", "locations": [ { "city": "Boynton Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06488742" }, { "nct_id": "NCT06843980", "title": "MOTION Clinical Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis, Knee" ], "interventions": [ { "name": "MISHA Knee System", "type": "DEVICE" }, { "name": "Non-Surgical Treatment", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Moximed", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 100, "start_date": "2025-02-13", "completion_date": "2030-06-30", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-10-25T11:06:53.610Z", "location_count": 9, "location_summary": "Davis, California • Oceanside, California • Sacramento, California + 6 more", "locations": [ { "city": "Davis", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Oak Brook", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06843980" }, { "nct_id": "NCT04786691", "title": "How do You Take Your Coffee Before Anesthesia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anesthesia", "Aspiration", "Fasting" ], "interventions": [ { "name": "Addition of half and half to coffee", "type": "OTHER" }, { "name": "Addition of non-dairy creamer to coffee", "type": "OTHER" }, { "name": "Black", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Arkansas", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 18, "start_date": "2021-03-01", "completion_date": "2021-06-30", "has_results": true, "last_update_posted_date": "2023-03-23", "last_synced_at": "2026-10-25T11:06:53.610Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04786691" }, { "nct_id": "NCT01160848", "title": "Photoactive Porphyrins (PAP) Levels After Topical Visonac Application in Acne Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Area cleaned with saline water and occluded with Tegaderm", "type": "DRUG" }, { "name": "Area cleaned with saline water", "type": "DRUG" }, { "name": "Area cleaned with Ethyl alcohol solution", "type": "DRUG" }, { "name": "Visonac left on the skin for 24 hours in facial area one", "type": "DRUG" }, { "name": "Visonac wiped off after one hour", "type": "DRUG" }, { "name": "Visonac left on the skin 24 hours in facial area two", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Photocure", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "12 Years to 35 Years" }, "enrollment_count": 20, "start_date": "2010-08", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2014-05-20", "last_synced_at": "2026-10-25T11:06:53.610Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01160848" }, { "nct_id": "NCT01297400", "title": "Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Burns" ], "interventions": [ { "name": "Investigational Drug, MW-III", "type": "DRUG" }, { "name": "Silvadene® Cream 1% [Silver Sulfadiazine]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Skingenix, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2022-03-11", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-03-16", "last_synced_at": "2026-10-25T11:06:53.610Z", "location_count": 4, "location_summary": "Phoenix, Arizona • Sacramento, California • Washington D.C., District of Columbia + 1 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Sacramento", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT01297400" }, { "nct_id": "NCT02661958", "title": "Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "S6G5T-3", "type": "DRUG" }, { "name": "S6G5T-1", "type": "DRUG" }, { "name": "S6G5T-5", "type": "DRUG" }, { "name": "S6G5T-6", "type": "DRUG" }, { "name": "S6G5T-7", "type": "DRUG" }, { "name": "S6G5T-8", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": null, "sex": "ALL", "summary": "9 Years and older" }, "enrollment_count": 726, "start_date": "2016-05", "completion_date": "2017-10", "has_results": false, "last_update_posted_date": "2019-09-19", "last_synced_at": "2026-10-25T11:06:53.610Z", "location_count": 34, "location_summary": "Anaheim, California • Cerritos, California • Chula Vista, California + 27 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02661958" } ] }